US Stock MarketDetailed Quotes

CRXM Gene Biotherapeutics

Watchlist
  • 0.000001
  • 0.0000000.00%
Close Feb 9 16:00 ET
64.93Market Cap0.00P/E (TTM)

About Gene Biotherapeutics Company

Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company. The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease, and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde in December 2003 and is headquartered in San Diego, CA.

Company Profile

SymbolCRXM
Company NameGene Biotherapeutics
Founded2003
CEOMr. Christopher J. Reinhard
MarketPink Market
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11230 Sorrento Valley Road,Suite 220
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-414-1477

Company Executives

  • Name
  • Position
  • Salary
  • Christopher J. Reinhard
  • Chairman of the Board, President and Chief Executive Officer
  • --
  • Dr. Gabor M. Rubanyi,M.D.,PhD
  • Chairman of Scientific Advisory Board and Chief Scientific Officer
  • --
  • Dr. Lois A. Chandler
  • Chief Operating Officer
  • --
  • Jiayue Zhang
  • Executive Chairman of the Board
  • --
  • Duane Linstrom
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg